Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

61230

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the proposals for value-based assessments published by the National Institute for Healthand Care Excellence on 22 March 2014 on patients' access to new cancer medicines.
tabling member printed	Lord Walton of Detchant
uin	HL190
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>A consultation on the National Institute for Health and Care Excellence's (NICE) proposals for value assessment is ongoing and no decisions have yet been made about any potential changes to NICE's methods of technology appraisal.</p><p> </p><p>The consultation will close on 20 June and we would encourage all those with an interest, including patients, clinicians, the National Health Service, industry, researchers and academic experts, to make their views known as part of this process.</p><p> </p> answering member printed Earl Howe grouped question UIN HL191 question first answered 16/06/2014 11:27:57 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

61231

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what effect the new proposals for value-based assessments published by the National Institute for Healthand Care Excellence on 22 March 2014 have had on the availability of treatments to patients with (1) those forms of cancer which are more frequent in older people, and (2) rare types of cancer.
tabling member printed	Lord Walton of Detchant
uin	HL191
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>A consultation on the National Institute for Health and Care Excellence's (NICE) proposals for value assessment is ongoing and no decisions have yet been made about any potential changes to NICE's methods of technology appraisal.</p><p> </p><p>The consultation will close on 20 June and we would encourage all those with an interest, including patients, clinicians, the National Health Service, industry, researchers and academic experts, to make their views known as part of this process.</p><p> </p> answering member printed Earl Howe grouped question UIN HL190 question first answered 16/06/2014 11:27:57 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

61232

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Thromboembolism
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what estimate they have made of the uptake of innovative anti-coagulant medicines in the management of venous thromboembolism in the National Health Service.
tabling member printed	Lord Walton of Detchant
uin	HL192
answer	answer is ministerial correction date of answer 18/06/2014 answer text <p>Decisions on the prescribing of medicines are a matter for clinicians in discussion with their patients.</p><p> </p><p>Dabigatran (Pradaxa), apixaban (Eliquis) and rivaroxaban (Xarelto) are recommended in National Institute for Health and Care Excellence (NICE) technology appraisal guidance for use in reducing the risk of venous thromboembolism (VTE)after hip or knee replacement surgery. Rivaroxaban is also recommended as a treatment option for adults with deep vein thrombosis and in the prevention of recurrent deep vein thrombosis and pulmonary embolism. National Health Service commissioners are legally required by regulations to fund those treatments recommended by NICE in its technology appraisal guidance.</p><p> </p><p>NHS England has advised that it is working with the Health &amp; Social Care Information Centre as part of the National VTE Prevention Programme to analyse the uptake of medicines in this area.</p><p> </p><p>The Health and Social Care Information Centre's report on the <em>Use of NICE appraised medicines in the NHS in England 2012</em>, published on 21 January 2014, includes information on the usage of dabigatran etexilate, apixaban and rivaroxaban for prevention of venous thromboembolism after hip or knee replacement surgery in secondary care.</p><p> </p><p>The report showed an increase in mean usage over time during 2010-2012 and an increase in the total use of the drugs over time, which had accelerated in 2012. The report is available at:</p><p> </p><p>www.hscic.gov.uk/catalogue/PUB13413/use-nice-app-med-nhs-exp-stat-eng-12-rep.pdf</p> answering member printed Earl Howe question first answered 18/06/2014 11:54:45 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

61233

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Thromboembolism
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure access to innovative medicines in order to improve the management of venous thromboembolism in the National Health Service.
tabling member printed	Lord Walton of Detchant
uin	HL193
answer	answer is ministerial correction date of answer 18/06/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) has recommended a number of treatments for the prevention of venous thromboembolism. National Health Service commissioners are legally required by regulations to fund those treatments recommended by NICE in its technology appraisal guidance.</p><p> </p><p>We understand that NHS England has established an Innovation Programme which ensures the commissioning system promotes and supports participation of the NHS in research, translating scientific developments into benefits for patients.</p> answering member printed Earl Howe question first answered 18/06/2014 11:53:38 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

61277

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco: Packaging
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the challenge made via the World Trade Organisation to the introduction of standardised tobacco packaging in Australia, in the light of their plans to consider introducing a similar regime in the United Kingdom.
tabling member printed	Lord Palmer
uin	HL237
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>The Government is aware of the complaints made in respect of the Australian plain packaging legislation, within The World Trade Organization (WTO) dispute procedures. The Government continues to carefully consider all issues relevant to the introduction of standardised packaging of tobacco products, including all legal aspects.</p><p> </p><p>In accordance with normal practice, the Government is not intending to disclose legal advice received.</p> answering member printed Earl Howe question first answered 23/06/2014 15:58:48 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer

61278

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco: Packaging
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to continue with the introduction of restrictions on the display of tobacco in smaller shops from April 2015, in the light of their plans to consider introducing standardised tobacco packaging; and, if so, what is their rationale for doing so.
tabling member printed	Lord Palmer
uin	HL238
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>Legislation to end the open display of tobacco products in shops has been made and will come into force for all shops on 6 April 2015.</p><p> </p><p>Standardised packaging of tobacco products is a policy that is still under consideration by the Government. No final decisions have been made regarding the policy. The Government will be publishing a final, short consultation that will contribute to final decision-making.</p> answering member printed Earl Howe question first answered 23/06/2014 15:57:32 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer

61279

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco: Packaging
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government from which companies and organisations, other than those involved in the tobacco industry, they have received representations since October 2013 regarding their plans to consider introducing standardised tobacco packaging.
tabling member printed	Lord Palmer
uin	HL239
answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The information cannot be provided without incurring disproportionate cost.</p> answering member printed Earl Howe question first answered 24/06/2014 13:26:29 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer

61280

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco: Packaging
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of introducing standardised tobacco packaging on the United Kingdom's ability to trade globally.
tabling member printed	Lord Palmer
uin	HL240
answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The Government continues to carefully consider all issues relevant to the introduction of standardised packaging of tobacco products, including aspects related to trade.</p><p> </p><p>The Government will shortly publish a final, short consultation that will contribute to final decision-making on whether standardised packaging will be introduced. The Government encourages anyone with an interest to respond to the consultation, which may include evidence on the impact of standardised packaging on trade.</p> answering member printed Earl Howe question first answered 24/06/2014 12:16:24 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer

61281

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Consumer Goods: Marketing
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the Chantler Review's suggestion that there is a spillover effect, whereby the branding of consumer goods intended for adult consumption may also appeal to young people; and what assessment they have made of the implications for consumer goods other than tobacco that might be deemed to put children at risk.
tabling member printed	Lord Palmer
uin	HL241
answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>Tobacco is treated uniquely in regulatory terms, because it is a uniquely harmful consumer good. All smoking is addictive and harmful to health. Around half of all regular smokers are eventually killed by a smoking-related illness, and on average, smokers who die from a smoking-related illness lose around 16 years of life. Smoking is the primary cause of preventable morbidity and premature death, accounting for almost 80,000 deaths in England each year, some 18% of all deaths of adults aged 35 and over.</p><p> </p><p>Regulatory controls on tobacco are commensurate with the potential harm to the health of smokers and others that it can cause. Over the past decade in particular, tobacco has become increasingly regulated and controlled as further evidence about the harm to health from smoking has emerged. Tobacco, therefore, is subject to greater levels of regulation than other consumer products.</p> answering member printed Earl Howe question first answered 24/06/2014 16:34:08 answering member 2000 label Biography information for Earl Howe
tabling member	3192 label Biography information for Lord Palmer

60545

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Centres: Worcester
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they are taking any action to prevent the closure of the Worcester Walk-In Health Centre; and if so, what.
tabling member printed	Lord Hunt of Kings Heath
uin	HL134
answer	answer is ministerial correction date of answer 18/06/2014 answer text <p>The reconfiguration of local health services is a matter for the National Health Service. All service changes should be led by clinicians and be in the best interests of patients, not driven from the top down.</p><p> </p><p>We are aware that the local consultation on the <em>Worcestershire Urgent Care Strategy</em> closed on 9 April 2014. The clinical commissioning groups in Worcestershire are now considering the responses. No decisions have yet been made.</p> answering member printed Earl Howe grouped question UIN HL135 HL136 question first answered 18/06/2014 11:58:25 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath